CannaPharmaRX, Inc.
CPMD
$0.00
$0.00-4.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 46.45% | 66.09% | 404.62% | 5,175.97% | 4,278.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.45% | 66.09% | 404.62% | 5,175.97% | 4,278.29% |
| Cost of Revenue | 4.53% | -1.60% | 215.28% | 362.78% | 376.62% |
| Gross Profit | 12.87% | 20.52% | -166.39% | -232.55% | -247.92% |
| SG&A Expenses | 71.10% | 37.85% | 15,535.29% | -1.05% | -43.89% |
| Depreciation & Amortization | -- | -- | -880.90% | -228.95% | -129.81% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.33% | 4.57% | 224.53% | 209.10% | 124.04% |
| Operating Income | -1.78% | 9.33% | -180.95% | -126.38% | -68.35% |
| Income Before Tax | -1,066.93% | -12.37% | -630.59% | -1,001.72% | 116.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,066.93% | -12.37% | -630.59% | -1,001.72% | 116.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,066.93% | -12.37% | -630.59% | -1,001.72% | 116.92% |
| EBIT | -1.78% | 9.33% | -180.95% | -126.38% | -68.35% |
| EBITDA | 53.77% | 58.72% | -156.53% | -217.25% | -106.36% |
| EPS Basic | -1,005.56% | 45.42% | -179.49% | -37.70% | 108.78% |
| Normalized Basic EPS | -239.53% | 76.84% | 66.89% | 79.39% | 116.10% |
| EPS Diluted | -1,005.56% | 45.42% | -179.49% | -37.70% | 108.78% |
| Normalized Diluted EPS | -239.53% | 76.84% | 66.89% | 79.39% | 116.10% |
| Average Basic Shares Outstanding | 0.44% | 13.55% | 30.64% | 59.53% | 103.05% |
| Average Diluted Shares Outstanding | 0.44% | 13.55% | 30.64% | 59.53% | 103.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |